The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...

Managing buffers in bioprocessing remains a largely manual process, requiring space and resources and often creating bottlenecks that increase costs and decrease efficiency. Researchers from many of ...

BILLERICA, Mass.--(BUSINESS WIRE)--Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, today announced a joint partnership with Boston BioProducts, a cGMP ...

Nucleus Biologics launched the Krakatoa ® K500, which the company says is the first bioreactor-scale, pod-based media and buffer manufacturing system designed to deliver sterile solutions on demand ...

Produces 35–500 liters of sterile media and buffers on demand at point-of-use, reducing cost, complexity, and lead times Pod-based, closed single-use system with integrated analytics, QR-code-driven ...

The "Buffer Preparation Market Industry Trends and Global Forecasts to 2035: Distribution by Scale of Operation, Type of System Component, Type of Buffer Formulation, Type of Molecule, Type of ...

Framing media/buffer risk around lead time, consistency, and expiry aligns raw-material controls with clinical urgency and unpredictable consumption patterns. On-site manufacture can reduce ...

NB-Lux™ AI connects formulation through GMP manufacturing in a single AI-enabled ecosystem, accelerating timelines and improving transparency from R&D through Excipient GMP. Built off NB-Lux™, the ...